Robotic training for children with spinal muscular atrophy
Part of Brain & nervous system clinical trials.
This study tests different stiffness settings on a robotic exercise machine during arm and leg training for children with SMA. The goal is to see which setting works best to improve muscle strength and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 12 years old.
- Your child must have a diagnosis of spinal muscular atrophy (SMA).
- Your child must be able to sit upright without help from others or support devices.
- If your child is on SMA medication (like nusinersen or risdiplam), the dose must be stable for at least 6 months before the study and must not change during the study.
- Your child must be healthy enough to participate safely and must be able to complete the study procedures, including MRI, electromyography (a test of muscle electrical activity), and nerve conduction tests.
- Your child's blood pressure must be within a normal range for their age, sex, and height.
- Your child must be able to understand and follow the study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable devices (like smartwatches or activity trackers) to monitor movement and motor development in young children with spinal muscular atrophy (SMA), a rare genetic condition affecting muscle strength. The goal is to see if wearables can track disease progression and treatment response better than traditional clinic visits.
This trial tests whether a special type of physiotherapy using horseback riding can help improve movement and function in children with spinal muscular atrophy. It is a gentle, supported therapy that may help with strength, balance, and coordination.
This trial tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) is safe and tolerable for people with spinal muscular atrophy (SMA). It may help improve muscle function by activating low motor neurons.
This study compares two robot-assisted rehabilitation programs to see which one helps children and young adults with spinal muscular atrophy (SMA) improve their movement and function better. You may join if you have SMA (types 1-4), are up to 21 years old, and are already receiving medication for SMA.
This study tests whether a robotic device called Bambini Kids can safely help children with cerebral palsy improve their walking and movement. The robot assists with gait training—guided walking practice—to see if it helps strengthen muscles and improve mobility.
This study looks at how safely using a pediatric robotic exoskeleton over the long term can improve how children walk. It’s for children ages 3–17 who have certain movement or spine-related conditions and who can meet walking and joint-movement requirements.
Hear when a new Spinal Muscular Atrophy (SMA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.